Metabolic reprogramming and interventions in endometrial carcinoma.

Li, Jiajia; Yang, Hongmei; Zhang, Lingyi; Zhang, Songling; Dai, Yun

Li, Jiajia; Yang, Hongmei; Zhang, Lingyi; Zhang, Songling; Dai, Yun.

Afiliação

Li J; The Laboratory of Cancer Precision Medicine, the First Hospital of Jilin University, Changchun, Jilin 130061, China; Department of Gynecologic Oncology, Gynecology and Obstetrics Center, the First Hospital of Jilin University, Changchun, Jilin 130012, China.
Yang H; Department of Critical Care Medicine, the First Hospital of Jilin University, Changchun, Jilin 130012, China.
Zhang L; Department of Gynecology and Obstetrics, the Second Hospital of Jilin University, Changchun, Jilin 130041, China.
Zhang S; Department of Gynecologic Oncology, Gynecology and Obstetrics Center, the First Hospital of Jilin University, Changchun, Jilin 130012, China. Electronic address: slzhang@jlu.edu.cn.
Dai Y; The Laboratory of Cancer Precision Medicine, the First Hospital of Jilin University, Changchun, Jilin 130061, China. Electronic address: daiyun@jlu.edu.cn.

Biomed Pharmacother ; 161: 114526, 2023 May.

Article em En | MEDLINE | ID: mdl-36933381

Assuntos

Neoplasias do Endométrio; Metabolismo Energético; Humanos; Feminino; Glicólise; Fosforilação Oxidativa; Ciclo do Ácido Cítrico; Neoplasias do Endométrio/tratamento farmacológico

Palavras-chave

Chemoresistance; Endometrial carcinoma; Glycolysis; Metabolic reprogramming; Metabolic syndrome; Oxidative phosphorylation

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias do Endométrio / Metabolismo Energético Limite: Female / Humans Idioma: En Revista: Biomed Pharmacother Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google